JAN 18, 2018 8:00 AM PST

Unravel the exome odyssey: overcome the challenges of exon-level CNV detection

Speakers
  • Head of Cytogenomics and Laboratory Director, Perkin Elmer Genomics
    Biography
      Dr. Chaubey is an ABMGG-board certified diplomate in clinical cytogenetics/genomics and clinical molecular genetics/genomics. She is also a fellow of the American College of Medical Genetics and Genomics (FACMG). Previously, Dr. Chaubey was the Director of the Cytogenomics Laboratory at Greenwood Genetic Center. She received her Doctorate degree (PhD) from Guru Nanak Dev University, Amritsar, India and completed her post-doctoral studies at Center for Cellular and Molecular Biology (CCMB), Hyderabad, India and University of Illinois at Chicago (UIC).
    • Medical Geneticist, Children's National Medical Center
      Biography
        Dr. Kristina Cusmano-Ozog earned her medical degree at the University of South Florida where she also completed her training in pediatrics. She then relocated to Stanford University for training in Medical Genetics and Clinical Biochemical Genetics. She remained on staff for 3 years before moving to Washington DC where she accepted a faculty position at Children's National in 2011. In 2014, she took a brief hiatus to obtain additional training in Clinical Molecular Genetics through the National Institutes of Health. Dr. Cusmano-Ozog is ABMGG certified in Clinical Genetics, Clinical Biochemical Genetics and Clinical Molecular Genetics. Currently, she is an attending physician in the Division of Genetics and Metabolism and Co-directs the Biochemical Genetics and the Human Molecular Diagnostics laboratories at Children's National in Washington, DC.

      Abstract

      DATE: January 18, 2018
      TIME: 08:00am PST, 11:00am EST

      Current exon-level arrays and NGS techniques for CNV detection are plagued with a high number of false-positive calls and are challenging from a cost perspective when verifying numerous exon aberrations with orthogonal methods. Relevant gene lists continue to grow such that custom del/dup arrays out-date quickly and create laboratory inefficiencies with implementation and verification of new designs. These are only a few of the pain-points users experience given the current options in the marketplace for exon-level CNV analysis.

      Children's National Medical Center and Greenwood Genetic Center utilize a new, research tool for exon-level CNV detection, the Applied Biosystems™ CytoScan™ XON Suite. This tool comprehensively detects single-exon deletions and duplications in a cost-effective manner and can be used to complement NGS mutation analysis with its reliable exon-level CNV detection. This unique solution offers reporting flexibility whereby you may utilize your preferred gene list or customize your analysis to include various gene-level tiers selected for clinical research relevance. Thus, the user determines the areas of interest and is able to expand or restrict analysis for reporting.

      Both Children's National Medical Center and Greenwood Genetic Center were early access sites for the new CytoScan XON Suite and will be sharing their perspective, experience, and research cases thus far.

      Learning Objectives:

      • Understand the current challenges of exon-level analysis
      • Understand how a novel exon-level CNV assay can be used to overcome these challenges
      • Identify research cases that may benefit from an exon-level CNV assay

       

      For Research Use Only. Not for use in diagnostic procedures.


      Show Resources
      You May Also Like
      FEB 26, 2020 9:00 AM PST
      C.E. CREDITS
      FEB 26, 2020 9:00 AM PST
      DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
      APR 07, 2020 8:00 AM PDT
      C.E. CREDITS
      APR 07, 2020 8:00 AM PDT
      DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
      MAY 08, 2020 10:00 AM PDT
      C.E. CREDITS
      MAY 08, 2020 10:00 AM PDT
      DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
      OCT 08, 2020 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      OCT 08, 2020 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
      JUN 09, 2020 10:00 AM PDT
      C.E. CREDITS
      JUN 09, 2020 10:00 AM PDT
      DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
      JUN 23, 2020 10:00 AM PDT
      C.E. CREDITS
      JUN 23, 2020 10:00 AM PDT
      DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
      Loading Comments...
      Show Resources
      Attendees
      • See more